166
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma

, , , , , , , , & show all
Pages 29-37 | Received 22 Jul 2002, Published online: 13 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jonathan Schelfhout, Machaon Bonafede, Katherine Cappell, Ashley L. Cole, Janna Manjelievskaia & Amit D. Raval. (2020) Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant. Current Medical Research and Opinion 36:1, pages 33-41.
Read now
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, Suzanne R Hayman & Shaji K Kumar. (2006) High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma. Expert Review of Anticancer Therapy 6:3, pages 343-360.
Read now

Articles from other publishers (15)

Juliana Matos Pessoa, Eurides Leite da Rosa, André Dias Américo, Camila Lucena Motta, Cleyton Zanardo de Oliveira, Rosana Rocha Concilio, Jose Ulysses Amigo Filho, Ana Cynira Franco Marret, Arlette Edna Lazar, Breno Moreno De Gusmão, Phillip Scheinberg & Fábio Rodrigues Kerbauy. (2022) Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study. Bone Marrow Transplantation 57:8, pages 1313-1318.
Crossref
Shuangshuang Fu, Chi-Fang Wu, Michael Wang & David R. Lairson. (2019) Cost Effectiveness of Transplant, Conventional Chemotherapy, and Novel Agents in Multiple Myeloma: A Systematic Review. PharmacoEconomics 37:12, pages 1421-1449.
Crossref
Shankar Prinja, Gunjeet Kaur, Pankaj Malhotra, Gaurav Jyani, Raja Ramachandran, Pankaj Bahuguna & Subhash Varma. (2017) Cost-Effectiveness of Autologous Stem Cell Treatment as Compared to Conventional Chemotherapy for Treatment of Multiple Myeloma in India. Indian Journal of Hematology and Blood Transfusion 33:1, pages 31-40.
Crossref
Gunjan L. Shah, Aaron N. Winn, Pei-Jung Lin, Andreas Klein, Kellie A. Sprague, Hedy P. Smith, Rachel Buchsbaum, Joshua T. Cohen, Kenneth B. Miller, Raymond Comenzo & Susan K. Parsons. (2015) Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results–Medicare Database. Biology of Blood and Marrow Transplantation 21:10, pages 1823-1829.
Crossref
U. Rochau, B. Jahn, V. Qerimi, E.A. Burger, C. Kurzthaler, M. Kluibenschaedl, E. Willenbacher, G. Gastl, W. Willenbacher & U. Siebert. (2015) Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example. Critical Reviews in Oncology/Hematology 94:2, pages 164-178.
Crossref
Alessandro Corso, Silvia Mangiacavalli, Federica Cocito, Cristiana Pascutto, Virginia Valeria Ferretti, Alessandra Pompa, Roberta Ciampichini, Lara Pochintesta & Lorenzo G. Mantovani. (2013) Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis. PLoS ONE 8:9, pages e75047.
Crossref
P. Casassus. (2013) Traitement du myélome multiple. EMC - Hématologie 8:1, pages 1-16.
Crossref
Jaime M. Preussler, Ellen M. Denzen & Navneet S. Majhail. (2012) Costs and Cost-Effectiveness of Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 18:11, pages 1620-1628.
Crossref
Nandita KheraSteven B. Zeliadt & Stephanie J. Lee. (2012) Economics of hematopoietic cell transplantation. Blood 120:8, pages 1545-1551.
Crossref
Jennifer G. Gaultney, W.K. Redekop, Pieter Sonneveld & Carin A. Uyl-de Groot. (2011) Critical review of economic evaluations in multiple myeloma: An overview of the economic evidence and quality of the methodology. European Journal of Cancer 47:10, pages 1458-1467.
Crossref
Yu-Feng Lin, David R. Lairson, Wenyaw Chan, Xianglin L. Du, Kathryn S. Leung, Alana A. Kennedy-Nasser, Caridad A. Martinez, Stephen M. Gottschalk, Catherine M. Bollard, Helen E. Heslop, Malcolm K. Brenner & Robert A. Krance. (2010) The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia. Biology of Blood and Marrow Transplantation 16:9, pages 1272-1281.
Crossref
Jeffrey A. Jones, Muzaffar H. Qazilbash, Ya-Chen T. Shih, Scott B. Cantor, Catherine D. Cooksley & Linda S. Elting. (2008) In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies. Cancer 112:5, pages 1096-1105.
Crossref
K. Moeremans & L. Annemans. (2006) An update: Health economics of managing multiple myeloma. European Journal of Cancer 42:11, pages 1684-1691.
Crossref
Andrew Briggs, Martin Buxton, Mike Drummond, Ron GoereeMark J. SculpherAndrew R. Willan. (2016) Unfinished Symphony: A Tribute to the Life and Career of Bernie O’Brien (1959–2004). Medical Decision Making 24:5, pages 538-544.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:2, pages 91-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.